首页|混合型肝细胞癌临床病理特征及优势成分截断值分析

混合型肝细胞癌临床病理特征及优势成分截断值分析

扫码查看
目的 分析混合型肝细胞癌-胆管癌(cHCC-CC)中与预后相关的肝细胞癌(HCC)和肝内胆管癌(ICC)成分比例截断值,为肿瘤治疗提供依据.方法 收集2015年1月至2021年1月于福建医科大学孟超肝胆医院进行手术的46例cHCC-CC患者的临床病理及随访资料,同时选取同期行手术的HCC患者和ICC患者各30例作为对照组,收集其相临床病理资料,并进行术后随访,使用t检验、2x检验及Kaplan-Meier生存曲线比较cHCC-CC和HCC及ICC的临床及预后特点,最后利用X-tile软件分析cHCC-CC肿瘤成分比例的最佳截断值.结果 cHCC-CC患者平均发病年龄小于ICC 患者[(54.33±12.55)岁 比(61.20±11.21)岁,t=-2.433,P<0.05],cHCC-CC 患者血清甲胎蛋白(AFP)水平≥400 U/ml 比例高于 ICC 患者[30.43%(14/46)比 0.00%(0/0),x2=11.190,P<0.05],并且乙型肝炎病毒(HBV)阳性率也高于ICC患者[80.43%(37/46)比36.66%(11/30),x2=16.948,P<0.05],但 cHCC-CC 患者淋巴结转移率低于 ICC 患者[10.86%(5/46)比36.66%(11/30),x2=7.270,P<0.05].cHCC-CC患者中肿瘤直径≥5 cm者占比明显高于HCC患者[71.73%(33/46)比 46.66%(14/30),x2=4.837,P<0.05],并且 HCC-CC 患者中组织学分级低分化者占比低于 HCC 患者[67.39%(31/46)比 90.00%(27/30),x2=5.135,P<0.05].cHCC-CC组患者术后总生存率明显高于 ICC 组[69.56%(32/46)比 26.67%(8/30),x2=8.733,P<0.05].通过X-tile软件分析得出cHCC-CC中ICC成分占比最佳截断值为15%,≥15%ICC成分组总生存期明显优于 3%~14%ICC 成分组[75.67%(28/37)比 44.44%(4/9),x2=5.654,P<0.05].结论 cHCC-CC中HCC及ICC成分所占比例与预后密切相关.
Analysis of clinicopathological characteristics and dominant components of mixed hepatocellular carcinoma
Objective The proportion cutoff value of hepatocellular carcinoma(HCC)associated with prognosis and intrahepatic cholangiocarcinoma(ICC)components in mixed hepatocellular carcinoma combined hepatocellular-cholangiocarcinoma(cHCC-CC)was analyzed to provide a theoretical basis for tumor treatment.Methods The clinical pathology and follow-up data of 46 cHCC-CC patients from Janu-ary 2015 to January 2021,and 30 of HCC patients and ICC patients during the same period were selected for the clinical and prognostic characteristics of cHCC-CC,HCC and HCC and ICC,and the best cut-off value of cHCC-CC was analyzed using X-tile software.Results The mean age of onset of cHCC-CC pa-tients was less than that in ICC patients[(54.33±12.55)years vs.(61.20±11.21)years,t=-2.433,P<0.05].Serum alpha-fetoprotein(AFP)level in cHCC-CC patients was higher than that in ICC patients[30.43%(14/46)vs.0.00%(0/0),x2=11.190,P<0.05],and the positive rate of hepatitis B virus(HBV)in cHCC-CC patients was higher than that in ICC patients[80.43%(37/46)vs.36.66%(11/30),x2=16.948,P<0.05].However,the rate of lymph node metastasis in cHCC-CC patients was lower than that in ICC patients[10.86%(5/46)vs.36.66%(11/30),x2=7.270,P<0.05].The pro-portion of 5 cm in cHCC-CC patients was significantly higher than in HCC pateints[71.73%(33/46)vs.46.66%(14/30),x2=4.837,P<0.05].The proportion of histologically poorly differentiated in HCC-CC patients was significantly lower than in HCC patents[67.39%(31/46)vs.90.00%(27/30),x2=5.135,P<0.05].The overall postoperative survival rate of patients in the cHCC-CC group was sig-nificantly higher than that in the ICC group[69.56%(32/46)vs.26.67%(8/30),x2=8.733,P<0.05].The X-tile software analysis showed that the optimal cut-off of ICC component in cHCC was 15%,and the overall survival of 15%ICC component was significantly better than that of 3%-14%ICC compo-nent[75.67%(28/37)vs.44.44%(4/9),x2=5.654,P<0.05].Conclusion The proportion of HCC and ICC components in cHCC-CC is closely related to the prognosis.

Hepatocellular carcinomaIntrahepatic cholangiocarcinomaPrognostic factors

张丽娜、张宇、王雪芳、陈怡、吴丽霞、林科灿、陈丽红

展开 >

福建医科大学孟超肝胆医院病理科,福州 350028

福建医科大学基础医学院病理学系,福州 350004

福建医科大学孟超肝胆医院肝胆外科,福州 350028

肝细胞癌 肝内胆管癌 预后因素

福建省卫生健康委医学创新课题福州市科技计划

2023CXA0512022-S-008

2024

中华实验外科杂志
中华医学会

中华实验外科杂志

CSTPCD
影响因子:0.759
ISSN:1001-9030
年,卷(期):2024.41(4)
  • 7